Breast Lift in IL
Breast Lift in IL section, includes general infrmation about Breast Lift Procedure, Breast Lift IL Local News, Breast Lift IL Surgeon Locator and other Breast Lift related material.
Breast Lift Procedure
A mastopexy or breast lift is a surgical procedure performed to reshape the breast and return it to a more youthful position. Drooping of the breast may occur after pregnancy as well as aging. Frequently a breast implant may be used in conjunction with a breast lift in order to achieve better results. Depending on the amount of breast lifting that needs to be accomplished, different techniques may be used that involve different incisions. Generally, the more lifting that is required, the larger the incision (and therefore the scar).
Other Breast Lift Procedures
All Breast Procedures
Breast Lift IL (current)
IL Breast Reduction
IL Breast Implants
IL Implant Removal
IL Armpit Incision
More IL info...
Illinois Understand Illinois is a mostly flat plains state, with the majority being farmland except for the south, which is hilly and forrested. Most of Illinois is sparsely populated except for the northeast corner where Chicago is.
Illinois Get out This article is an outline and needs more content. It has a template, but there is not enough information present. Please plunge forward and help it grow!
Plastic Surgery News...
- The April 2008 edition of ‘Drug Safety Update’ from the MHRA discusses the availability of further evidence to suggest that the long-term use of combined oral contraceptives or progestogen-only injectable contraceptives is associated with a small increased risk of cervical cancer. It refers to the findings from a large analysis of data from epidemiological studies (Lancet 2007; 370:1609-21 – see link above), which found that:
• The current use of combined oral contraceptives (COCs) for 5 years or longer is accompanied by an increased risk of cervical cancer (relative risk 1.90 [95% CI 1.69–2.13]).
• Women who use COCs for 5 years from age 20 years have increased cumulative incidence of cervical cancer at age 50 years from 38 cases per 10,000 (in never-users) to 40 cases per 10,000 (i.e., an extra two cases per 10,000)
• Women who use COCs for 10 years from age 20 years have increased cumulative incidence of cervical cancer at age 50 years from 38 cases per 10,000 (in never-users) to 45 cases per 10,000 (i.e., an extra seven cases per 10,000)
• Risk falls when COCs are stopped; after about 10 years, risk reaches the same level as that for never-users of COCs.
• The risk of cervical cancer in users of progestogen-only injectable contraceptives (i.e., Depo-Provera and Noristerat) may be similar to that for COC users.
The MHRA article notes that no epidemiological data on cervical cancer risk associated with use of Evra® (a combined hormonal contraceptive patch), NuvaRing®, (a combined hormonal intravaginal contraceptive), progestogen-only pills, Implanon® (a progestogen-only implant), or Mirena® (a progestogen-only intrauterine device) are currently available. It discusses cervical screening as a method of reducing the risk of cervical cancer, and the upcoming introduction of routine HPV vaccination.
The MHRA has produced an information sheet and Question and Answer document for users of COCs advising them of the latest evidence regarding risk of cervical cancer and what it means for them; please see the links above for further information.
- Textronics, Inc. has received U.S. Food and Drug Administration (FDA) clearance to market its textile-based ECG Electrode for use in general electrocardiograph monitoring and recording procedures. The company's heart-sensing fabric offers a comfortable alternative to adhesive electrodes and metal wristbands that are commonly used with most ECG instruments on the market.